Compare RZLT & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
Current Price
| Metric | RZLT | NEN |
|---|---|---|
| Founded | 2010 | 1977 |
| Country | United States | United States |
| Employees | N/A | 45 |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 221.8M |
| IPO Year | N/A | N/A |
| Metric | RZLT | NEN |
|---|---|---|
| Price | $2.34 | $64.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | ★ 15.5M | 2.0K |
| Earning Date | 02-11-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 7.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.33 |
| Revenue | N/A | ★ $87,362,592.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.09 |
| Revenue Growth | N/A | ★ 7.63 |
| 52 Week Low | $1.07 | $63.00 |
| 52 Week High | $11.46 | $84.00 |
| Indicator | RZLT | NEN |
|---|---|---|
| Relative Strength Index (RSI) | 34.06 | 43.10 |
| Support Level | $1.87 | $63.00 |
| Resistance Level | $2.43 | $64.50 |
| Average True Range (ATR) | 0.30 | 0.81 |
| MACD | 0.17 | 0.10 |
| Stochastic Oscillator | 52.40 | 39.10 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.